Physician profile
Luv Singh
NPI 1649536830
$17,049.59
in general payments reported to CMS, 2019-2025
20 companies · $2,301 in 2025
The $2,301 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $170 · 2021: $1,251 · 2022: $129 · 2023: $444 · 2024: $787 · 2025: $2,301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,775 · Travel and Lodging: $728 · Consulting Fee: $28.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,775.32 |
| Travel and Lodging | $727.51 |
| Consulting Fee | $28.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $6,812.26 | 2019 | |
| Stryker Corporation | $3,573.24 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Actishield |
| Arthrex, INC. | $3,292.34 | 2019-2023 | Knee & Hip Instruments |
| Rattan and Associates | $1,388.09 | 2019-2024 | |
| Sportstek Medical, INC | $776.00 | 2019 | |
| Wright Medical Technology, INC. | $737.79 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $175.66 | 2025 | |
| Next Science LLC | $57.54 | 2024 | Blastx, Surgx, Xperience |
| Orthofix Medical, INC. | $39.16 | 2022-2023 | Physio-Stim |
| Endo Pharmaceuticals INC. | $34.63 | 2019-2020 | |
| Vericel Corporation | $22.60 | 2022 | |
| Depuy Synthes Sales INC. | $20.84 | 2024 | Orthovisc, Monovisc |
| Flower Orthopedics Coporation | $18.08 | 2024 | |
| Medtronic, INC. | $16.82 | 2025 | V-Loc 180 |
| Ethicon US, LLC | $16.26 | 2025 | Stratafix, Dermabond Prineo, Vistaseal |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $15.90 | 2020 | |
| Genentech USA, INC. | $13.63 | 2019 | |
| Merck Sharp & Dohme LLC | $13.53 | 2023 | Bridion |
| Arteriocyte Medical Systems, INC. | $13.37 | 2024 | Magellan |
| Abbott Laboratories | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luv Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.